Prelude Capital Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,800
Closed -$326K 1563
2024
Q1
$326K Buy
6,800
+1,832
+37% +$97.9K 0.02% 852
2023
Q4
$323K Sell
4,968
-7,800
-61% -$470K 0.02% 702
2023
Q3
$835K Buy
+12,768
New +$803K 0.05% 337
2023
Q2
Sell
-8,023
Closed -$495K 1392
2023
Q1
$495K Buy
+8,023
New +$481K 0.03% 462
2022
Q2
Sell
-2,346
Closed -$213K 2119
2022
Q1
$213K Buy
+2,346
New +$192K 0.01% 1239

Other funds holding NARI

Prelude Capital Management's NARI Position: Q2 2024 in Review

Prelude Capital Management sold out of Inari Medical, Inc. Common Stock (NARI) in Q2 2024, closing a stake of 6,800 shares — an estimated $326K sold.

Prelude Capital Management first reported a position in NARI in Q1 2022 and held it in 5 quarters. The position peaked at $835K in Q3 2023. 243 funds tracked by Wall St. Rank hold NARI as of Q2 2024.

  • Prelude Capital Management reported no remaining Inari Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Prelude Capital Management sold 6,800 Inari Medical, Inc. Common Stock shares in Q2 2024, an estimated $326K.
  • Prelude Capital Management first reported a position in Inari Medical, Inc. Common Stock in Q1 2022 and held it in 5 quarters.
  • Prelude Capital Management's Inari Medical, Inc. Common Stock position peaked at $835K in Q3 2023.
  • 243 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q2 2024.

Based on Prelude Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.